Skip to main content
. Author manuscript; available in PMC: 2011 Nov 15.
Published in final edited form as: Cancer Res. 2010 Nov 9;70(22):9319–9328. doi: 10.1158/0008-5472.CAN-10-1783

Figure 6.

Figure 6

Carboplatin treatment prior to BPD-PDT does not produce a synergistic interaction. No synergism was observed with the reverse treatment order, as evaluated by fraction of residual tumor (A) (p=0.3326), and tumor viability (B) (p=0.1368) (interaction term from ANCOVA for both treatment response metrics), relative to no treatment (grey dashed lines).